Iopamidol - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for iopamidol and what is the scope of patent protection?
Iopamidol
is the generic ingredient in eighteen branded drugs marketed by Baxter Hlthcare, Hainan Poly, Hospira, Cook Imaging, Fresenius Kabi Usa, Abbvie, Bracco, and Sanochemia Corp Usa, and is included in fourteen NDAs. Additional information is available in the individual branded drug profile pages.There are eleven drug master file entries for iopamidol. Three suppliers are listed for this compound.
Summary for iopamidol
| US Patents: | 0 |
| Tradenames: | 18 |
| Applicants: | 8 |
| NDAs: | 14 |
| Drug Master File Entries: | 11 |
| Finished Product Suppliers / Packagers: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 79 |
| Clinical Trials: | 25 |
| Patent Applications: | 5,724 |
| What excipients (inactive ingredients) are in iopamidol? | iopamidol excipients list |
| DailyMed Link: | iopamidol at DailyMed |
Recent Clinical Trials for iopamidol
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Chongqing Emergency Medical Center | N/A |
| Army Medical Center of PLA | N/A |
| National Cancer Institute (NCI) | N/A |
Pharmacology for iopamidol
| Drug Class | Radiographic Contrast Agent |
| Mechanism of Action | X-Ray Contrast Activity |
Medical Subject Heading (MeSH) Categories for iopamidol
Anatomical Therapeutic Chemical (ATC) Classes for iopamidol
US Patents and Regulatory Information for iopamidol
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hainan Poly | IOPAMIDOL | iopamidol | INJECTABLE;INJECTION | 217134-004 | Apr 9, 2024 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Bracco | ISOVUE-M 300 | iopamidol | INJECTABLE;INJECTION | 018735-004 | Dec 31, 1985 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Bracco | ISOVUE-M 200 | iopamidol | INJECTABLE;INJECTION | 018735-001 | Dec 31, 1985 | AP1 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Hainan Poly | IOPAMIDOL | iopamidol | INJECTABLE;INJECTION | 217134-003 | Apr 9, 2024 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Sanochemia Corp Usa | SCANLUX-300 | iopamidol | INJECTABLE;INJECTION | 090394-001 | Jun 18, 2010 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hainan Poly | IOPAMIDOL | iopamidol | INJECTABLE;INJECTION | 217134-001 | Sep 27, 2023 | AP2 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Hainan Poly | IOPAMIDOL | iopamidol | INJECTABLE;INJECTION | 215382-002 | Feb 27, 2023 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for iopamidol
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Bracco | ISOVUE-200 | iopamidol | INJECTABLE;INJECTION | 020327-001 | Oct 12, 1994 | ⤷ Sign Up | ⤷ Sign Up |
| Bracco | ISOVUE-300 | iopamidol | INJECTABLE;INJECTION | 018735-002 | Dec 31, 1985 | ⤷ Sign Up | ⤷ Sign Up |
| Bracco | ISOVUE-300 | iopamidol | INJECTABLE;INJECTION | 020327-003 | Oct 12, 1994 | ⤷ Sign Up | ⤷ Sign Up |
| Bracco | ISOVUE-M 200 | iopamidol | INJECTABLE;INJECTION | 018735-001 | Dec 31, 1985 | ⤷ Sign Up | ⤷ Sign Up |
| Bracco | ISOVUE-370 | iopamidol | INJECTABLE;INJECTION | 020327-004 | Oct 12, 1994 | ⤷ Sign Up | ⤷ Sign Up |
| Bracco | ISOVUE-M 300 | iopamidol | INJECTABLE;INJECTION | 018735-004 | Dec 31, 1985 | ⤷ Sign Up | ⤷ Sign Up |
| Bracco | ISOVUE-370 | iopamidol | INJECTABLE;INJECTION | 018735-003 | Dec 31, 1985 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
